Comparative Study Between Internal Fixtion And Primary Subtalar Arthrodesis In Comminuted Intra-Articular Calcaneal Fracture

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAhmed Gamal Ibrahim Saleh

About this trial

This study is to compare clinical outcome of Sanders type III or IV intra-articular calcaneal fracture treated with open reduction and internal fixation (ORIF) versus ORIF and primary subtalar arthrodesis (PSTA).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Sanders type 3 and 4 intra articular calcaneal fracture within 14 day of injury

Disqualifiers

patient with open injury, concomitant foot injury, vascular compromise and prior subtalar pathology

Trial design

Design model

Parallel

Treatments tested in this trial

  • Primary Subtalar Arthrodesis

    Procedure/Surgery

    Patients undergo primary subtalar arthrodesis via an extended lateral approach. The articular cartilage of the subtalar joint is removed, the calcaneal morphology is restored, and fixation is achieved using cannulated compression screws with a locking plate. Postoperative care follows the same protocol as the ORIF group. This intervention is distinguished from other surgical techniques by performing fusion as the primary treatment in severely comminuted Sanders type III and IV fractures, aiming to reduce the risk of post-traumatic subtalar arthritis.

  • Open reduction and internal fixation

    Procedure/Surgery

    Patients undergo open reduction and internal fixation of displaced intra-articular calcaneal fractures through an extended lateral approach. Fracture reduction is achieved under fluoroscopic guidance, restoring Bohler's and Gissane's angles. Fixation is performed using a locking calcaneal plate with screws. Postoperative care includes immobilization in a cast or splint, non-weight bearing for 8 weeks, followed by a standardized physiotherapy program. This procedure is distinguished from other calcaneal fracture treatments by the use of locking plate technology and precise anatomical reduction for Sanders type III and IV fractures

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Primary Subtalar Arthrodesis GroupExperimental treatment 1 intervention
Group B: Open Reduction and Internal FixationExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Orthopedic foot and ankle AOFAS

Time frame
2,4,6,8,12 weeks,6 months and 1.5years after operation
2

Orthopedic foot and ankle score (AOFAS)

Time frame
2'4'8'12 weeks' 6 months, and 1.5 years after surgery

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ahmed Gamal Ibrahim Saleh

Lead sponsor

Al-Azhar University

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: